Omeros (OMER) Share-based Compensation (2010 - 2026)
Omeros' Share-based Compensation was $1.62 million in Q2 2026, down 21.5% from $2.07 million a year earlier and down 14.2% from the prior quarter.
Powered by 
Analysis
Omeros (OMER) Share-based Compensation (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Omeros' Share-based Compensation was $7.18 million through Jun 30, 2026, down 25.0% year-over-year; for FY2025, it was $8.19 million, down 21.9% from FY2024.
- Share-based Compensation has now declined for four consecutive years, with a five-year compound annual growth rate of -11.3% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $10.49 million in FY2024 (-9.9%), $11.65 million in FY2023 (-17.2%), $14.07 million in FY2022 (-20.2%) and $17.63 million in FY2021 (+18.1%).
- The Q2 2026 figure marks the lowest quarterly Share-based Compensation since Q2 2013.
- Compared with a year earlier, Share-based Compensation has declined for 17 straight quarters, with an average decline of 20.1% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was Q3 2021 (growth of 48.9%); the worst was Q4 2022 (a decline of 41.2%).
- Per Business Quant data, OMER's Share-based Compensation in the three quarters before Q2 2026 was $1.89 million (Q1 2026), $1.73 million (Q4 2025) and $1.94 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Omeros | 1.40 Bn | 1.40 Bn | 27.73 Mn | 1.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 Mn |
| Mar 31, 2026 | 1.89 Mn |
| Dec 31, 2025 | 1.73 Mn |
| Sep 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Mar 31, 2025 | 2.45 Mn |
| Dec 31, 2024 | 2.43 Mn |
| Sep 30, 2024 | 2.64 Mn |
| Jun 30, 2024 | 2.77 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Dec 31, 2023 | 2.69 Mn |
| Sep 30, 2023 | 3.24 Mn |
| Jun 30, 2023 | 2.77 Mn |
| Mar 31, 2023 | 2.95 Mn |
| Dec 31, 2022 | 3.26 Mn |
| Sep 30, 2022 | 3.84 Mn |
| Jun 30, 2022 | 3.07 Mn |
| Mar 31, 2022 | 3.89 Mn |
| Dec 31, 2021 | 5.55 Mn |
| Sep 30, 2021 | 5.69 Mn |
API Access
Omeros Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=OMER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "OMER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=OMER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();